FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant Depression - Forbes https://t.co/l76F9UgJ8g
— Discovery Institute (@discoverynj) March 8, 2019
from Twitter https://twitter.com/discoverynj
March 07, 2019 at 11:29PM
Friday, March 8, 2019
FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant Depression - Forbes https://t.co/l76F9UgJ8g
from Twitter https://twitter.com/discoverynj
March 07, 2019 at 11:29PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment